Tempus AI Reports Mixed Q1 2026 Results with Widened Net Loss and Significant CEO Selling Plan
summarizeSummary
Tempus AI reported strong 36.1% revenue growth and improved Adjusted EBITDA in Q1 2026, but net losses widened significantly. The company also disclosed a substantial Rule 10b5-1 selling plan by CEO Eric Lefkofsky.
check_boxKey Events
-
Strong Revenue Growth
Total net revenue increased 36.1% year-over-year to $348.1 million in Q1 2026, driven by both Diagnostics and Data & Applications segments.
-
Widened Net Loss
Net loss significantly widened to $125.9 million in Q1 2026, an 85.1% increase from $68.0 million in Q1 2025, primarily due to non-recurring tax benefits in the prior year and higher stock-based compensation.
-
Improved Operational Performance
Adjusted EBITDA showed significant improvement, narrowing to a loss of $2.8 million in Q1 2026 from a loss of $16.2 million in Q1 2025.
-
Solid Liquidity Position
The company reported $525.9 million in cash and equivalents as of March 31, 2026, projecting sufficient liquidity to fund operations for over 12 months.
auto_awesomeAnalysis
Tempus AI's Q1 2026 results present a mixed financial picture. While the company achieved robust revenue growth of 36.1% year-over-year, demonstrating continued demand for its diagnostics and data solutions, the net loss widened considerably. This increase in net loss is largely attributable to the absence of a significant non-recurring tax benefit recognized in Q1 2025 and a substantial rise in stock-based compensation expenses. Positively, the company's Adjusted EBITDA improved significantly, suggesting better underlying operational efficiency. Furthermore, Tempus AI affirmed a solid liquidity position, with sufficient cash and equivalents to cover its operating plan for more than a year. However, the disclosure of CEO Eric Lefkofsky's adoption of a Rule 10b5-1 plan to sell a substantial amount of shares (approximately $355.5 million) through controlled entities introduces a notable negative signal, indicating a significant planned distribution by a key insider. Investors will likely weigh the strong revenue growth and improved operational metrics against the widening net loss and the large insider selling plan.
At the time of this filing, TEM was trading at $50.42 on NASDAQ in the Technology sector, with a market capitalization of approximately $9.7B. The 52-week trading range was $41.73 to $104.32. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.